Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Halle (Saale) – page 23

335 clinical trials in Halle (Saale), Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Halle (Saale) at a glance
335
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

335 trials in Halle (Saale)

Open in trial search

Study on Midostaurin and Chemotherapy for Children with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Cytarabine
  • Sponsor:Novartis Pharma AG

Study on the Effectiveness and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International

Bladder cancer

Not recruiting

Study Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Janssen Cilag International

Study of Osimertinib and Chemotherapy for Patients with EGFR Mutation Positive Resectable Non-Small Cell Lung Cancer

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Colitis ulcerative

Not recruiting

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Study of Gilteritinib and Chemotherapy for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Cytarabine
  • Sponsor:Astellas Pharma Global Development Inc.

B-cell lymphoma+5

Not recruiting

Study on the Effects and Safety of Odronextamab for Adults with Previously Treated B-cell Non-Hodgkin Lymphoma

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Odronextamab
  • Sponsor:Regeneron Pharmaceuticals Inc.

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Binimetinib
  • Sponsor:Pfizer Inc.

Study of RO7247669, Tiragolumab, and Atezolizumab for Patients with Untreated Advanced Urothelial Cancer Ineligible for Platinum Chemotherapy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Study of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB

Other cities in Germany

The busiest research cities in the country

All 516 cities in Germany

Clinical research in Halle (Saale)

What the registry says about research in the country

01 Halle (Saale)
Oncology and Hematologic Malignancies
Clinical research in Halle (Saale) is strongly focused on cancer and blood disorders, with studies exploring new treatment options for solid tumors and leukemia, lymphoma, and related conditions. Neoplasms and hematologic malignancies Acute myeloid leukemia, lymphoma, and multiple myeloma Testing newer combinations and more effective treatment strategies Evaluating outcomes in advanced, relapsed, or high-risk disease Many studies in this area aim to improve survival, disease control, and treatment options for patients with limited standard choices.
Lung and Respiratory Diseases
Another major research area covers respiratory tract diseases, especially non-small cell lung cancer, small cell lung cancer, and chronic lung conditions such as COPD and pulmonary fibrosis. Non-small cell lung cancer and small cell lung cancer Chronic obstructive pulmonary disease, bronchiectasis, and idiopathic pulmonary fibrosis Assessing new therapies and maintenance approaches Improving symptom control and long-term respiratory outcomes The studies often focus on better disease management for both advanced cancers and chronic inflammatory lung disease.
Gastroenterology and Inflammatory Bowel Disease
Trials in digestive system diseases and immune-related disorders include important work on Crohn’s disease, ulcerative colitis, and other inflammatory conditions of the gut. Crohn’s disease and ulcerative colitis Coeliac disease and gastrointestinal inflammation Studying new immune-targeted treatments Improving control of active disease and remission rates These projects aim to reduce symptoms, support remission, and improve quality of life for people with chronic intestinal disease.
Cardiovascular and Stroke Research
Cardiovascular diseases are represented by studies on heart failure, atrial fibrillation, stroke, and related complications after surgery or acute vascular events. Heart failure and atrial fibrillation Acute ischemic stroke and vascular occlusion Testing ways to prevent complications and improve recovery Evaluating safer and more effective cardiovascular care Research in this field is aimed at lowering risk, improving emergency treatment, and supporting long-term heart and brain health.
Autoimmune and Immune-Mediated Disorders
Halle’s trial portfolio includes a broad set of studies on immune system diseases, including rheumatologic, skin-related, and other inflammatory conditions. Lupus erythematosus, hidradenitis suppurativa, and giant cell arteritis Atopic dermatitis and chronic spontaneous urticaria Exploring immune-modulating therapies Looking to reduce inflammation and improve daily functioning These studies reflect a strong interest in better control of chronic immune-driven disease.
Hematology, Bone Marrow Transplantation, and Blood Clotting Disorders
A significant share of research addresses myeloid disorders, myeloproliferative neoplasms, and complications linked to stem cell transplantation. Myelodysplastic syndromes, myelofibrosis, and essential thrombocythemia Graft-versus-host disease and transplant-related complications Evaluating better blood cancer and transplant treatments Improving safety and disease control in high-risk patients Much of this work focuses on patients with difficult-to-treat disease and the need for more precise supportive care.
Pediatric Oncology and Rare Childhood Diseases
The city also supports research into children’s cancers and other rare pediatric conditions, including tumors of the brain, blood, and soft tissue. Medulloblastoma, neuroblastoma, and rhabdomyosarcoma Acute lymphoblastic leukemia in children and adolescents Testing more effective and less burdensome treatment approaches Seeking better survival and long-term outcomes for young patients These trials often aim to refine treatment so that cure rates improve while limiting lasting harm.
Neurology and Nervous System Conditions
Research also includes nervous system diseases such as stroke, multiple sclerosis, spinal cord injury, and certain rare neurological disorders. Secondary progressive multiple sclerosis Acute spinal cord injury and idiopathic sudden hearing loss Evaluating therapies that may improve recovery or slow progression Exploring care options for serious and uncommon neurological conditions These studies are aimed at improving function, symptom relief, and neurological outcomes over time.
Metabolic, Kidney, and Endocrine Conditions
Trials in nutritional and metabolic diseases and kidney-related disorders focus on conditions that affect energy balance, organ function, and long-term health. Obesity, metabolic disease, and mitochondrial disease Chronic kidney disease and kidney-related complications Studying ways to slow disease progression Assessing treatments that may improve overall organ health This area reflects interest in both common chronic illness and rarer inherited disorders.
Eye, Ear, and Other Diagnostic Research
Several studies address eye diseases, ear and nose conditions, and broader diagnostic techniques, showing a strong interest in improving how disease is detected and managed. Diabetic macular edema and other vision-threatening eye conditions Hearing loss and otologic disorders Improving diagnosis and monitoring Testing therapies that may preserve vision or sensory function These projects highlight the role of better diagnostics alongside treatment development in everyday clinical care.
Infectious Diseases, Surgery, and Public Health
There is also work on bacterial infections, viral diseases, surgical complications, and public health questions, including prevention and perioperative care. Viral and bacterial infections Surgical bleeding, infection prevention, and post-operative complications Evaluating supportive treatments and preventive strategies Improving safety in hospital and surgical settings These trials focus on practical clinical needs, from infection control to safer recovery after procedures.
Psychiatry and Behavioral Health
Some research in Halle addresses mental disorders and behavioral disciplines, reflecting interest in both emotional health and broader patient well-being. Attention deficit hyperactivity disorder and borderline personality disorder Studying approaches that may improve symptoms and functioning Supporting better understanding of complex behavioral conditions Exploring patient-centered care in mental health These studies contribute to broader clinical research beyond traditional somatic disease areas.
Women’s Health, Fertility, and Urogenital Disorders
Trials also include female and male urogenital diseases, pregnancy-related issues, and fertility-related concerns, showing a balanced interest in reproductive health. Pregnancy complications and vaginal infections Infertility and urogenital disorders Testing therapies for symptom relief and prevention Improving health outcomes for women and men These studies often aim to make everyday gynecologic and reproductive care more effective.
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.